Identification of N-benzothiazolyl-2-benzenesulfonamides as novel ABCA1 expression upregulators-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of N-benzothiazolyl-2-benzenesulfonamides as novel ABCA1 expression upregulators

Published:2020 Issue:3 Volume:11 Page:411-418
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Liu Hongtao¹²³⁴⁵,Jiang Xinhai⁶⁷⁸⁹⁴,Gao Xinfeng⁵¹⁰¹¹¹²⁴,Tian Wenhua⁵¹⁰¹¹¹²⁴,Xu Chen⁵¹⁰¹¹¹²⁴,Wang Ruizhi⁵¹⁰¹¹¹²⁴,Xu Yanni⁶⁷⁸⁹⁴,Wei Liping¹³¹⁴¹⁵¹⁶¹⁷,Cao Feng¹⁸¹⁹²⁰⁴,Li Wenyan⁵¹⁰¹¹¹²⁴^ORCID

Affiliation:

1. Department of Pharmacy

2. Hebei General Hospital

3. Shijiazhuang 05005

4. China

5. Hebei Key Laboratory of Organic Functional Molecules

6. NHC Key Laboratory of Biotechnology of Antibiotics

7. Institute of Medicinal Biotechnology

8. Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS&PUMC)

9. Beijing 100050

10. College of Chemistry and Materials Science

11. Hebei Normal University

12. Shijiazhuang

13. Department of Cardiology

14. Tianjin Union Medical Center

15. Nankai University Affiliated Hospital

16. Tianjin 300121

17. P. R. China

18. Department of Cardiology & National Clinical Research Center of Geriatrics Disease

19. Chinese PLA General Hospital

20. Beijing 100853

Abstract

A series of N-benzothiazolyl-2-benzenesulfonamides were designed and synthesized as novel ABCA1 expression upregulators.

Funder

Natural Science Foundation of Hebei Province

National Natural Science Foundation of China

Hebei Normal University

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2020/MD/C9MD00556K

Reference25 articles.

1. Causes and Predictors of Death in Patients With Coronary Heart Disease (from the Heart and Soul Study)

2. Lifetime competing risks between coronary heart disease mortality and other causes of death during 50 years of follow-up

3. Effect of Coronary Artery Calcium as a Subclinical Atherosclerosis Measure on Cardiovascular Events or Other Causes of Death

4. Redistribution of heart failure as the cause of death: the Atherosclerosis Risk in Communities Study

5. Table of Contents, Editor's Choice, Highlights

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Biological Active Sulfonamide based Hybrid Compounds Part A: Two-Component Sulfonamide Hybrids;Current Medicinal Chemistry;2023-02

2. Apolipoprotein A1-Related Proteins and Reverse Cholesterol Transport in Antiatherosclerosis Therapy: Recent Progress and Future Perspectives;Cardiovascular Therapeutics;2022-01-10

3. Eelectrosynthesis of benzothiazole derivatives via C–H thiolation;Heterocyclic Communications;2022-01-01

4. Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics;Computational and Structural Biotechnology Journal;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3